Close Menu

When Roche yesterday announced its $5.7 billion hostile takeover bid for Illumina, reactions on Twitter were varied and swift, ranging from the humorous — like Stuart Glenn's depiction of what a potential acquisition might be like — to the concerned — "If Roche plans to do to DNA sequencing what it did to PCR, then a lot of genomicists are

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.

According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.

In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.